博济医药：子公司将“硫酸氨基葡萄糖胶囊”技术转让给盘龙药业

Core Viewpoint - The announcement indicates that Boji Pharmaceutical (300404) has signed a technology transfer agreement with its subsidiary Guangzhou Huasheng Pharmaceutical Co., Ltd. and Shanxi Panlong Pharmaceutical Group Co., Ltd. for the transfer of technology related to "Glucosamine Sulfate Capsules" for a total fee of 4.5 million yuan, which is expected to positively impact the company's operating performance [1]. Group 1 - Boji Pharmaceutical and its subsidiary have entered into a technology transfer agreement with Panlong Pharmaceutical [1] - The total transfer fee for the technology is 4.5 million yuan [1] - Successful implementation of the transaction is anticipated to have a positive effect on the company's operating performance [1]